Live Earnings Conference Call: Cerus will host a live Q1 2025 earnings call on May 1, 2025 at 4:30PM ET. Follow this link to get details and listen to Cerus' Q1 2025 earnings call when it goes live. Get details. Cerus (CERS) Competitors $1.32 -0.01 (-0.38%) As of 02:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. STAA, OSUR, ANIK, UTMD, COO, WST, ALGN, MMSI, ICUI, and HAEShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Cerus vs. STAAR Surgical OraSure Technologies Anika Therapeutics Utah Medical Products Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics STAAR Surgical (NASDAQ:STAA) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, community ranking, profitability, analyst recommendations, risk, dividends and earnings. Does the MarketBeat Community favor STAA or CERS? Cerus received 281 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 54.12% of users gave STAAR Surgical an outperform vote. CompanyUnderperformOutperformSTAAR SurgicalOutperform Votes28954.12% Underperform Votes24545.88% CerusOutperform Votes57072.34% Underperform Votes21827.66% Which has higher earnings & valuation, STAA or CERS? STAAR Surgical has higher revenue and earnings than Cerus. STAAR Surgical is trading at a lower price-to-earnings ratio than Cerus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTAAR Surgical$313.90M2.88-$20.21M-$0.41-44.63Cerus$180.27M1.39-$37.49M-$0.11-11.95 Is STAA or CERS more profitable? STAAR Surgical has a net margin of -6.44% compared to Cerus' net margin of -11.60%. STAAR Surgical's return on equity of -3.35% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets STAAR Surgical-6.44% -3.35% -2.67% Cerus -11.60%-40.55%-11.12% Do insiders and institutionals believe in STAA or CERS? 96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 78.4% of Cerus shares are owned by institutional investors. 1.0% of STAAR Surgical shares are owned by insiders. Comparatively, 3.4% of Cerus shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer STAA or CERS? In the previous week, STAAR Surgical had 2 more articles in the media than Cerus. MarketBeat recorded 8 mentions for STAAR Surgical and 6 mentions for Cerus. STAAR Surgical's average media sentiment score of 1.00 beat Cerus' score of 0.37 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, STAA or CERS? STAAR Surgical has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500. Do analysts prefer STAA or CERS? STAAR Surgical currently has a consensus price target of $24.25, suggesting a potential upside of 32.52%. Cerus has a consensus price target of $3.50, suggesting a potential upside of 166.16%. Given Cerus' stronger consensus rating and higher probable upside, analysts clearly believe Cerus is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STAAR Surgical 1 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummarySTAAR Surgical and Cerus tied by winning 9 of the 18 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$251.38M$4.34B$5.50B$7.96BDividend YieldN/A39.94%5.11%4.23%P/E Ratio-11.9530.6722.6318.55Price / Sales1.3955.17397.30103.38Price / CashN/A51.0838.1834.62Price / Book4.536.056.704.25Net Income-$37.49M$68.71M$3.23B$248.27M7 Day Performance-3.31%-0.13%1.36%1.28%1 Month Performance-4.71%-2.30%3.85%3.75%1 Year Performance-23.55%22.45%15.87%5.31% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.0386 of 5 stars$1.32-0.4%$3.50+166.2%-21.0%$251.38M$180.27M-11.95290News CoverageSTAASTAAR Surgical4.3893 of 5 stars$16.53-2.1%$24.25+46.7%-60.3%$815.34M$313.90M-40.32960Upcoming EarningsPositive NewsOSUROraSure Technologies4.5644 of 5 stars$2.87-4.0%$5.50+91.6%-43.5%$214.68M$185.83M19.13840Upcoming EarningsANIKAnika Therapeutics4.0625 of 5 stars$14.03+0.1%$21.67+54.4%-43.9%$198.89M$119.91M-2.11300Positive NewsUTMDUtah Medical Products2.3526 of 5 stars$52.50+0.4%N/A-21.8%$172.31M$40.90M13.29180Earnings ReportNews CoverageCOOCooper Companies3.3189 of 5 stars$78.70-1.0%$110.25+40.1%-8.3%$15.74B$3.93B40.3614,000Positive NewsWSTWest Pharmaceutical Services4.6428 of 5 stars$206.02+2.0%$332.50+61.4%-40.9%$14.89B$2.89B30.8010,700Earnings ReportDividend AnnouncementAnalyst RevisionALGNAlign Technology4.3529 of 5 stars$172.22+0.5%$256.90+49.2%-38.6%$12.61B$4.00B30.7023,200Earnings ReportAnalyst ForecastNews CoverageGap UpMMSIMerit Medical Systems3.9729 of 5 stars$89.60-1.4%$114.33+27.6%+27.5%$5.29B$1.36B43.926,850Earnings ReportShort Interest ↑Analyst RevisionICUIICU Medical3.8758 of 5 stars$136.72-1.4%$162.67+19.0%+39.5%$3.35B$2.38B-29.9214,500Upcoming EarningsNews CoveragePositive NewsHAEHaemonetics4.6258 of 5 stars$57.03-0.2%$101.22+77.5%-31.5%$2.87B$1.37B22.452,820Upcoming EarningsNews CoveragePositive News Related Companies and Tools Related Companies STAA Competitors OSUR Competitors ANIK Competitors UTMD Competitors COO Competitors WST Competitors ALGN Competitors MMSI Competitors ICUI Competitors HAE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CERS Stock Free CERS Stock Alerts